Commonwealth Equity Services’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.25M | Buy |
|
|||||
|
2025
Q2 | $602K | Buy |
|
|||||
|
2025
Q1 | $314K | Buy |
|
|||||
|
2024
Q4 | $174K | Sell |
|
|||||
|
2024
Q3 | $1.33M | Sell |
|
|||||
|
2024
Q2 | $1.09M | Buy |
|
|||||
|
2024
Q1 | $277K | Buy |
|
|||||
|
2023
Q4 | $175K | Sell |
|
|||||
|
2023
Q3 | $205K | Buy |
|
|||||
|
2023
Q2 | $146K | Hold |
|
|||||
|
2023
Q1 | $213 | Hold |
|
|||||
|
2022
Q4 | $114K | Buy |
|
|||||
|
2022
Q3 | $62K | Hold |
|
|||||
|
2022
Q2 | $50K | Buy |
|
|||||
|
2022
Q1 | $43K | Buy |
|
|||||
|
2021
Q4 | $34K | Buy |
|
|||||
|
2021
Q3 | $46K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $60K | Buy |
|
|||||
|
2019
Q2 | $63K | Buy |
|
|||||
|
2019
Q1 | $62K | Buy |
|
|||||
|
2018
Q4 | $38K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $44K | Sell |
|
|||||
|
2016
Q1 | $47K | Buy |
|
|||||
|
2015
Q4 | $49K | Buy |
|
|||||
|
2015
Q3 | $52K | Buy |
|
|||||
|
2015
Q2 | $57K | Sell |
|
|||||
|
2015
Q1 | $82K | Buy |
|
|||||
|
2014
Q4 | $70K | Buy |
|
|||||
|
2014
Q3 | $101K | Buy |
|
|||||
|
2014
Q2 | $236K | Buy |
|
|||||
|
2014
Q1 | $237K | Buy |
|